BTG2 and SerpinB5, a novel gene pair to evaluate the prognosis of lung adenocarcinoma.

ABSTRACT:

Introduction

Lung adenocarcinoma (LUAD), as the most frequent pathological subtype of non-small cell lung cancer, is often characterized by poor prognosis and low 5-year survival rate. Exploriton of new biomarkers and accurate molecular mechanisms for effectively predicting the prognosis of LUAD patients is still necessary. Presently, BTG2 and SerpinB5, which play important roles in tumors, are studied as a gene pair for the first time with the aim of exploring whether they can be used as potential prognostic markers.

Methods

Using the bioinformatics method to explore whether BTG2 and SerpinB5 can become independent prognostic factors, and explore their clinical application value and whether they can be used as immunotherapeutic markers. In addition, we also verify the concl

SUBMITTER: Yang W 

PROVIDER: S-EPMC10064863 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature